









Markets
/
Stocks
/
nasdaq-amrn
/

Amarin Corporation PLC

AMRN

View Detailed Chart

15.160USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

314.87MMarket Cap

LossP/E TTM



Amarin Corporation PLC

15.160

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

+4.41%

5 Days

-1.46%

1 Month

-9.38%

6 Months

+36.77%

Year to Date

+56.29%

1 Year

+18.44%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts

SELL

Current Rating

16.000

Target Price

5.54%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Amarin Corporation PLC

AMRN

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(4)

Buy(7)

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.500

Neutral

RSI(14)

49.953

Neutral

STOCH(KDJ)(9,3,3)

41.847

Buy

ATR(14)

0.635

High Vlolatility

CCI(14)

-77.083

Neutral

Williams %R

48.623

Neutral

TRIX(12,20)

-0.002

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

14.858

Buy

MA10

15.156

Buy

MA20

15.798

Sell

MA50

14.322

Buy

MA100

11.961

Buy

MA200

11.384

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Ticker SymbolAMRN

CompanyAmarin Corporation PLC

CEOMr. Aaron D. Berg

Websitehttps://amarincorp.com/